Literature DB >> 1964632

Plasma lipolytic activity and substrate oxidation after intravenous administration of heparin and a low molecular weight heparin fragment.

E Persson1, J Nordenström, P Nilsson-Ehle, L Hagenfeldt, J Wahren.   

Abstract

This study examines the effects of heparin and a low molecular weight heparin (LMWH) fragment on plasma lipolytic activity and substrate oxidation. Indirect calorimetry was performed continuously in healthy male subjects receiving a constant infusion of fat emulsion (0.2 g min-1) and glucose (0.8 g min-1) during a period of 4 h. After 2 h an infusion of heparin (n = 6) or LMWH (n = 6) (100 antifactor Xa units kg-1) or saline (n = 6) was given over 1 h. Plasma concentration of the fat emulsion decreased by 76 +/- 5% with heparin and by 12 +/- 7% with LMWH (P less than 0.01). In the case of LMWH the initial fall was followed by a consistent rise in fat emulsion concentration for the entire remaining study period. Compared to the control experiments, plasma FFA increased five times with heparin and three times with LMWH (P less than 0.05). The average respiratory quotient (RQ) and energy expenditure (EE) increased constantly during the study period and did not differ significantly between the groups. In all groups the average increase in glucose oxidation was 40-50%, while fat oxidation decreased to a comparable extent. Infusions of heparin and LMWH had no effect on RQ or EE. A microcalorimetric study on isolated rat adipocytes in buffer solutions containing glucose, fat emulsion, heparin or LMWH was also made. The heat output from the adipocytes was not influenced by the presence of heparin or LMWH. In conclusion, infusion of heparin resulted in a pronounced increase in FFA availability, whereas LMWH exerted a less marked lipolytic effect. However, the heparin-induced elevations in plasma FFA were not accompanied by measurable rises in lipid oxidation rate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964632     DOI: 10.1111/j.1475-097x.1990.tb00449.x

Source DB:  PubMed          Journal:  Clin Physiol        ISSN: 0144-5979


  7 in total

1.  Impact of hyperlipidaemia on the orbital bone cefotaxime levels in rats.

Authors:  G Panitsa; A Panitsas; A Potamianou; J Messari; J Vovou; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

2.  Challenges of cardiac inflammation imaging with F-18 FDG positron emission tomography.

Authors:  Pradeep Bhambhvani
Journal:  J Nucl Cardiol       Date:  2016-05-04       Impact factor: 5.952

3.  Effect of prolonged fasting and low molecular weight heparin or warfarin therapies on 2-deoxy-2-[18F]-fluoro-D-glucose PET cardiac uptake.

Authors:  Assuero Giorgetti; Gavino Marras; Dario Genovesi; Elena Filidei; Antonio Bottoni; Maurizio Mangione; Michele Emdin; Paolo Marzullo
Journal:  J Nucl Cardiol       Date:  2017-02-03       Impact factor: 5.952

4.  Turning the heart off: give it a second try?

Authors:  Nidaa Mikail; Fabien Hyafil
Journal:  J Nucl Cardiol       Date:  2022-06-02       Impact factor: 5.952

5.  Lipoprotein lipase in hemodialysis patients: indications that low molecular weight heparin depletes functional stores, despite low plasma levels of the enzyme.

Authors:  Birgit Näsström; Bernd Stegmayr; Gunilla Olivecrona; Thomas Olivecrona
Journal:  BMC Nephrol       Date:  2004-11-03       Impact factor: 2.388

Review 6.  Glucose-insulin therapy, plasma substrate levels and cardiac recovery after cardiac ischemic events.

Authors:  C J Zuurbier; H B Van Wezel
Journal:  Cardiovasc Drugs Ther       Date:  2008-04       Impact factor: 3.727

7.  F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the infection of heart.

Authors:  Eunjung Kong
Journal:  Yeungnam Univ J Med       Date:  2020-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.